INTRODUCTION
Published reports suggest a considerable geographical variation in the pathogenesis of acute pancreatitis (Table 1 ). This may account for the contradictory findings regarding the effectiveness of the commonly used therapeutic agents Propantheline Bromide (Pro-Banthine), Aprotinin and Glucagon.
In most studies, the majority of cases have been associated with biliary disease, an undetermined proportion having a stone in the ampulla of vater obstructing the common opening of the bile and pancreatic ducts so enabling bile to reflux into the pancreas (Opies syndrome). The study here reported was prompted by our own experience of the remarkable effectiveness of Glucagon not only in reducing mortality and morbidity of our patients, but also in controlling pain where it has proved as effective as Pethidine in the acute stages of the disease.
Our study is retrospective but allocation to treatment groups was random and treatment groups were statistically comparable in respect of age, sex and serum amylase levels (Tables 2 and 3) . give 
RESULTS
In the Glucagon group, three of the seventy patients (4%) died, none from pancreatitis, whereas in the Propantheline group, nine of the ninety died (10%), 34 five of them from uncontrolled pancreatitis. Table 4 shows the cause of deaths in the two groups. In 
